1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 1: Demographic, clinical, and imaging characteristics of index and control cases^{^a}
Factor Index (n = 6) Control (n = 25) Group Effect (P Value)
Age (yr) 39 (27–67) 35 (18–59) .39
Sex (% female) 67 68 .67
Anterior territory CBF baseline (mL/100 g/min) 36.6 (33.3–57.9) 50.2 (31.2–62.9) .14
Anterior territory CBF post-ACZ (mL/100 g/min) 34.3 (23.4–64.5) 63.7 (39.0–74.3) .007
Anterior change CBF (CVR) (%) −0.4 (−38.7–16.6) 26.3 (−8.2–60.5) .003
Posterior territory CBF baseline (mL/100 g/min) 41.7 (33.4–48.8) 38.8 (27.1–54.5) .36
Posterior territory CBF post-ACZ (mL/100 g/min) 54.2 (31.7–64.7) 55.6 (38.2–72.2) .39
Posterior change CBF (CVR) (%) 31.9 (−19.1–55.4) 39.1 (0.9–117.7) .16
Volume of acute infarcts following surgery (mL) 95.0 (17.0–181.0) 0 NA
Patients with acute (DWI+) infarcts on preop MRI (%) 4 (66.7%) 0 (0%) NA
Note:—ACZ indicates acetazolamide; preop, preoperative; NA, not applicable; DWI+, DWI with positive findings.
↵a Values are median (range) where applicable.